Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
11/2002
11/21/2002DE10125293A1 New anthranilamide derivatives and analogs containing heterocycle N-oxide group, as KDR/FLT tyrosine kinase inhibitors, used for e.g. treating psoriasis, restenosis, leukemia, arthritis, eye or kidney disease or arteriosclerosis
11/21/2002DE10123587A1 New cyanoanthranylamide derivatives, useful for treating e.g. psoriasis and Kaposi's sarcoma, are inhibitors of angiogenesis, acting selectively on specific tyrosine kinases
11/21/2002CA2447150A1 Processes for the synthesis of derivatives of 2,3-dihydro-1,4-dioxino-[2,3-f] quinoline
11/21/2002CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002CA2446749A1 Polymerisation catalyst
11/21/2002CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002CA2446605A1 Novel processes for the preparation of adenosine compounds and intermediates thereto
11/21/2002CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002CA2445477A1 Antitumor agents
11/21/2002CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/20/2002EP1258480A1 Pharmaceutical use of N-Carbamoylazole derivatives
11/20/2002EP1258478A1 Process for producing quinolonecarboxylic acids and intermediates thereof
11/20/2002EP1258252A1 Integrin expression inhibitors
11/20/2002EP1258244A1 High affinity ligands for nociceptin receptor ORL-1
11/20/2002EP1257550A1 Platelet adp receptor inhibitors
11/20/2002EP1257549A2 Matrix metalloproteinase inhibitors and uses thereof
11/20/2002EP1257547A1 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists
11/20/2002EP1257546A1 Kinase inhibitors
11/20/2002EP1257545A1 SELECTIVE iGLUR 5? RECEPTOR ANTAGONISTS
11/20/2002EP1257544A2 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage
11/20/2002EP1257543A1 Pyridinylimidazoles
11/20/2002EP1257539A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
11/20/2002EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002EP1257269A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives
11/20/2002EP1150969B1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
11/20/2002EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use
11/20/2002EP0954337B1 Intestinal absorption of nicotine to treat nicotine responsive conditions
11/20/2002EP0929530B1 Quinazoline derivatives and pharmaceutical compositions containing them
11/20/2002EP0925302B1 Palladium catalyzed indolization
11/20/2002EP0814840B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
11/20/2002EP0813424B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
11/20/2002EP0721453B1 Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
11/20/2002CN1380289A Amide capable of inhibiting ApoB-secretion/MTP
11/20/2002CN1094491C 2-{4-[4-(4,5-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and use thereof
11/20/2002CN1094490C Quinolein-2(1H)-one derivativs as serotonin antagonists
11/20/2002CN1094486C Benzal compound and preparation method
11/19/2002US6482955 Organometallic reagent reacted with an activated carboxylic acid to produce a ketone reacted with carbon disulfide and dihalomethane, further reacting the dithietane product with a secondary amine, and condensing the thioamide with hydrazine
11/19/2002US6482951 Isoindolin-1-one glucokinase activators
11/19/2002US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002US6482836 CRF antagonistic quino- and quinazolines
11/19/2002US6482835 Such as (r)-1-cyclopropyl-8-difluoromethoxy-7-(1-methyl-2,3-dihydro-1h-5-isoindolyl)-4-oxo-1,4-dihydro-3-quinolinecarboxyl ic acid methanesulfonate; chemical intermediates; bactericides; catalysis
11/19/2002US6482832 Heterocyclically substituted amides, their production and their use
11/19/2002US6482425 Parasiticidal combination
11/18/2002WO2001087855A1 Triazole derivatives
11/14/2002WO2002090355A1 N-aroyl cyclic amines
11/14/2002WO2002090352A2 Selective anthranilamide pyridine amides as inhibitors of vegfr-2 and vegfr-3
11/14/2002WO2002090351A1 Process for producing carbostyril derivative
11/14/2002WO2002090350A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
11/14/2002WO2002090349A1 N-oxide anthranylamide derivatives and their use as medicaments
11/14/2002WO2002090348A1 Sulfonamides
11/14/2002WO2002090347A1 Amide compounds
11/14/2002WO2002090346A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002WO2002090335A1 Azole compounds, process for preparation of the same and use thereof
11/14/2002WO2002090334A1 Isoquinolinone derivatives as parp inhibitors
11/14/2002WO2002090330A1 Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
11/14/2002WO2002090325A2 Benzazepinone alpha v integrin receptor antagonists
11/14/2002WO2002090317A1 Substituted cyclohexane-1,4-diamine derivatives
11/14/2002WO2002089800A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/14/2002WO2002089799A2 Use of dihydropyrazoles to increase erythropoietin and vasculari zation
11/14/2002WO2002089797A1 Treatment of adhd
11/14/2002WO2002089793A1 Sulfonamides
11/14/2002WO2002089792A1 Sulfonamides
11/14/2002WO2002089783A1 Substituted cyclohexan-1,4-diamine derivatives with constipating and peripheral analgesic properties
11/14/2002WO2002089745A2 Substituted n'-(arylcarbonyl)-benzhydrazides, n'-(arylcarbonyl)-benzylidene-hydrazides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/14/2002WO2002081453A8 Thiohydantoins and use thereof for treating diabetes
11/14/2002WO2002074764A3 Piperazine derivatives and their use as 5-ht1b ligands
11/14/2002WO2002072577A3 Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors.
11/14/2002WO2002068417A3 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/14/2002WO2002055014A3 Therapeutic chroman compounds
11/14/2002WO2002055013A3 Therapeutic chromone compounds
11/14/2002WO2002055012A3 Therapeutic heterocyclic compounds
11/14/2002WO2002024650B1 Pyridinone and pyridinethione derivatives having hiv inhibiting properties
11/14/2002WO2001097787A3 Use of microsomal triglyceride transfer protein (mtp) inhibitors for reducing the number of postprandial triglyceride-rich lipoprotein particles (pptrl)
11/14/2002US20020169336 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders
11/14/2002US20020169326 Fatty acid derivatives
11/14/2002US20020169322 Use of N-alkylamino-heterocylic compounds for the treatment of migraine
11/14/2002US20020169318 Novel thrombin inhibitors
11/14/2002US20020169200 Antitumor, antiinflammatory and antiarthritic agents, treating metastasis, restenosis, osteoporosis, inflammation, macular degeneration, and diabetic retinopathy
11/14/2002US20020169186 Tetrahydroquinoline derivatives as glycine antagonists
11/14/2002US20020169182 Neurotrophin antagonist compositions
11/14/2002US20020169180 Quinoline or quinazoline derivatives; antitumor agent, treating respiratory tract and gastrointestinal disorders
11/14/2002US20020169170 Arylpiperazines having activity at the serotonin 1A receptor
11/14/2002US20020169169 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
11/14/2002US20020169166 Benzimidazoles that are useful in treating sexual dysfunction
11/14/2002US20020169165 Substituted bicyclic derivatives for the treatment of abnormal cell growth
11/14/2002US20020169159 An acetamide derivative is useful for treatment of inflammatory and immune conditions and diseases; modulates the expressin and/or function of a chemokine receptor
11/14/2002US20020169156 Azacyclooctane and heptane derivatives, their preparation and use in therapy
11/14/2002US20020169155 A nitrogen-ring containing triheterocyclic compound is useful for treating a disease associated with aberrant leukocyte recruitment and/or activation
11/14/2002US20020169113 Orally available peptidic thrombin inhibitors
11/14/2002DE10122025A1 Verfahren zur Herstellung von Terpyridinen A process for preparing terpyridines
11/14/2002CA2453223A1 Selective anthranilamide pyridinamides as vegfr-2 and vegfr-3 inhibitors
11/14/2002CA2446735A1 Substituted cyclohexane-1,4-diamine derivatives with an anti-diarrhoea and peripheral analgesic action
11/14/2002CA2446652A1 Treatment of adhd
11/14/2002CA2446396A1 N-aroyl cyclic amines
11/14/2002CA2446387A1 Azole compound, process for producing the same and use thereof
11/14/2002CA2446365A1 Sulfonamides
11/14/2002CA2446051A1 Phthalazine derivatives with angiogenesis inhibiting activity
11/14/2002CA2445679A1 Benzazepinone alpha v integrin receptor antagonists
11/14/2002CA2444531A1 Isoquinolinone derivatives as parp inhibitors
11/13/2002EP1256580A1 Process for the preparation of terpyridyls
1 ... 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 ... 1080